Jazz Pharmaceuticals PLC at Wells Fargo Healthcare Conference Transcript
Good morning, everyone. I am David Maris, Specialty Pharmaceuticals Analyst for Wells Fargo Securities. Welcome to our Healthcare Conference and for kicking it off this morning. Today, we have the management team from Jazz Pharmaceuticals with us. Dan Swisher, the President and Chief Operating Officer; and Katherine Littrell, the Vice President of Investor Relations is joining us.
This is the fireside chat. So you saw, and we can put it up again if you have any questions that you want to text. There will also be a microphone and you can wave your arms. I have a bunch of questions as well, and so I'll be joining the company management on the -- in the fireside chat without our fire, but to kick off in just a second.
But I do want to thank everyone for their attendance at our healthcare conference. The last time I was in Boston, I was hitting from home plate at Fenway Park for a charity event here. And so -- and I got to meet my childhood hero, Carl Yastrzemski. So Boston and I have a fond
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |